Reply: Spastic paraplegia in 'dominant optic atrophy plus' phenotype due to OPA1 mutation
Author(s) -
Patrick YuWaiMan,
Patrick F. Chinnery
Publication year - 2011
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awr102
Subject(s) - atrophy , optic neuropathy , medicine , hereditary spastic paraplegia , pathology , spastic , exon , peripheral neuropathy , optic nerve , ophthalmology , phenotype , biology , genetics , endocrinology , gene , physical medicine and rehabilitation , cerebral palsy , diabetes mellitus
Sir, Pretegiani et al . (2011) describe a 28-year-old female with early-onset optic atrophy who subsequently developed slowly progressive spastic paraplegia. Electrophysiological studies did not suggest a peripheral neuropathy and additional investigations excluded a primary demyelinating process as the cause of her neurological deficits. Interestingly, this patient was eventually found to harbour a previously reported c.2708_2711delTTAG pathogenic deletion in exon 27 of OPA1 —the causative gene in the majority of patients with autosomal dominant optic atrophy. Based on this isolated observation, it is difficult to conclude that migraine and Duane retraction syndrome are causally related to this specific OPA1 mutation. In our original study in Brain , ∼5% of patients with dominant optic atrophy plus (DOA+) suffered from migraine, which is less than the …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom